5 Spine Surgeons Making News Nov. 13, 2020 Spine surgeon Ali Baaj, MD, is named chief of spine surgery at the University of Arizona College of Medicine-Phoenix and Banner-University Medical Center Phoenix. Becker's Spine Review
Paradise Valley Unified School District Going Back to Virtual Learning Only Due to COVID-19 Rise Nov. 13, 2020 As new COVID-19 cases continue to surge across the state, the Paradise Valley Unified School District has decided to return to virtual learning-only starting Nov. 23. "Everything is moving in the wrong direction. The holidays are coming. We have folks coming in from out of town. It's wise at this point. We're not anticipating it's going to be closed for one or two weeks and then open back up. We should think about a strategy for the winter," said Dr. Shad Marvasti, director of public health, prevention and health promotion with the University of Arizona College of Medicine – Phoenix. KPNX-TV (NBC) Phoenix
Study: Black Patients Get Worse Care After Cardiac Arrest Nov. 13, 2020 Dr. Khadijah Breathett, an assistant professor of cardiology at the University of Arizona College of Medicine, called the new findings "worrisome," partly because hospital care for these acute cardiac complications should be "fairly regimented and standardized." HealthDay
COVID-19 is Spreading Fastest in Smaller and More Rural Arizona Counties Nov. 12, 2020 The spread of COVID-19 in Arizona is behaving differently than it did in the summer, with spikes happening in rural areas such as Graham and Gila counties that had far fewer cases during the state's first surge. Rural counties such as Gila, Graham, Greenlee and Coconino are leading the statewide resurgence in terms of new case rates, according to Joe Gerald, an associate professor at University of Arizona's Mel and Enid Zuckerman College of Public Health who has been tracking the pandemic’s spread in Arizona for months. Arizona Republic
UArizona Expert: COVID Conditions Entering a 'Crisis' Nov. 12, 2020 Dr. Joe Gerald, an associate professor in the University of Arizona Zuckerman College of Public Health, provides and update in his weekly COVID-19 report. KNXV-TV (ABC) Phoenix
Personalized Cancer Vaccine Clinical Trial Shows Early Promise Nov. 12, 2020 Continued coverage: Promising results have come out of a new clinical trial at the University of Arizona Health Sciences investigating a personalized cancer vaccine for people with head and neck cancer. The researchers note that it's a very small study and still preliminary work, but their early results are looking good. IFL Science
Pandemic Shines Light on Complex Coexistence of Modern, Traditional Ways on Navajo Nation Nov. 12, 2020 Traditional healers, who once played critical roles in governance and health care in the Navajo Nation, are dwindling in number and influence, experts and community leaders say, even as a deadly coronavirus assaults the tribe. Michelle Kahn-John, a professor of nursing at the University of Arizona and secretary of the Diné Hataalii Association, is quoted. Arizona Daily Star
6 Breathing Exercises for Anxiety That Can Help You Feel Calmer Nov. 12, 2020 Beyond just feeling better and like you can get through the day a little easier (two major wins), finding ways to relieve stress and anxiety is also good for your physical health, says Ester Sternberg, MD, professor of medicine in the University of Arizona College of Medicine, Tucson, and research director of the Andrew Weil Center for Integrative Medicine. MSN
COVID-19: Vaccines Continue to Progress as More Proof of Long-Lasting Immunity Emerges Nov. 11, 2020 Researchers at the University of Arizona College of Medicine in Tucson have found that people who have had COVID-19 develop long-lasting immunity. Their study appears in the journal Immunity. Medical News Today
Moderna’s Personalized Cancer Vaccine Shows Promise Nov. 11, 2020 A clinical trial at the University of Arizona Health Sciences designed to study the safety and effectiveness of a personalized cancer vaccine in combination with the immunotherapy drug Pembrolizumab will expand its cohort after promising preliminary data was presented at the annual meeting of the Society for the Immunotherapy of Cancer. PharmaLive